Baxter International Inc (MIL:1BAX)
€ 32.01 0 (0%) Market Cap: 14.28 Bil Enterprise Value: 25.64 Bil PE Ratio: 145.90 PB Ratio: 1.89 GF Score: 45/100

Baxter International Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 19, 2020 / 02:00PM GMT
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Great. Good morning, and welcome to our next session here at the UBS Virtual Healthcare Conference. In the med tech track, we have management from Baxter International. I'm really pleased to be joined by Jay Saccaro, the CFO of the company; and also Clare Trachtman, VP of Investor Relations. And today, we'll go over a number of topics on the different businesses and COVID.

Just one word of orientation for the session. If you have any questions, you can always e-mail me or send your questions in through the webcast. There'll be about a 40-minute Q&A.

So to start, I just want to thank Jay and Clare for joining us.

Questions & Answers

Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

And Jay, maybe I'll kick it off to you with kind of a higher-level question. Talking about some of the shifting sands that we're seeing here. Baxter has

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot